- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Cognitive neuropsychiatry.
Displaying page 1 of 1.
EudraCT Number: 2019-004758-27 | Sponsor Protocol Number: IVIGPANSOpen | Start Date*: 2020-03-02 |
Sponsor Name:Gillberg Neuropsychiatry Centre | ||
Full Title: Intravenous immunoglobulin (IVIG) treatment in children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS): an open-label trial in South-western Sweden | ||
Medical condition: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a research diagnosis given to patients who have an abrupt, dramatic onset of neuropsychiatric symptoms including obsessions/compulsions and... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004023-24 | Sponsor Protocol Number: PRETEC-EPO | Start Date*: 2016-12-15 | ||||||||||||||||
Sponsor Name:Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet | ||||||||||||||||||
Full Title: Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with bipolar disorder and unipolar depression in remission (PRETEC-EPO) | ||||||||||||||||||
Medical condition: Bipolar disorder and unipolar depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002106-52 | Sponsor Protocol Number: CANBiS-AD | Start Date*: 2020-03-19 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: CANnabidiol for Behavioural Symptoms in Alzheimer’s Disease | |||||||||||||
Medical condition: Alzheimer's disease patients with BPSD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005007-12 | Sponsor Protocol Number: 039(C)MD21046 | Start Date*: 2023-02-17 | |||||||||||
Sponsor Name:Angelini Pharma S.p.A. | |||||||||||||
Full Title: Efficacy of Trazodone Once-a-Day for treatment of Major Depressive Disorder in patients with breast cancer. | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000565-23 | Sponsor Protocol Number: 2016-867 | Start Date*: 2017-03-03 | ||||||||||||||||||||||||||
Sponsor Name: | ||||||||||||||||||||||||||||
Full Title: TAILOR - a randomized clinical trial: Tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or schizophreniform psychosis in ... | ||||||||||||||||||||||||||||
Medical condition: Patients with newly diagnosed schizophrenia or schizophreniform psychosis in remission of psychotic symptoms | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
